YIANNA MANOLAKIS: Open Payments
NPI 1366800617 · BUFORD, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$663 in 33 payments from 16 companies in 2025. Trend: 2023 $672 · 2024 $713 · 2025 $663
Food & beverage: $663
| Company | Payments | Amount |
|---|---|---|
| Tris Pharma Inc | 7 | $137 |
| AstraZeneca Pharmaceuticals LP | 6 | $112 |
| Eisai Inc. | 2 | $62 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $59 |
| PFIZER INC. | 2 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| ABBVIE INC. | 2 | $30 |
| Esperion Therapeutics, Inc. | 1 | $29 |
| Corcept Therapeutics | 1 | $23 |
| Exact Sciences Corporation | 1 | $21 |
Products named: Dyanavel XR, Leqembi, XIFAXAN, AIRSUPRA, TRINTELLIX, NEXLETOL, NURTEC ODT, Korlym.
Industry payments across GA — which companies pay providers there.
